Literature DB >> 3280531

Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases.

J C Horiot1, J Pigneux, H Pourquier, S Schraub, E Achille, R Keiling, P Combes, R Rozan, C Vrousos, N Daly.   

Abstract

A French Cooperative study of 1383 cases with invasive carcinoma of the intact uterine cervix treated with radiation therapy alone, using the guidelines provided by G. H. Fletcher led to the following conclusions: The techniques of treatment were easily reproducible in 9 French centers, working in a prospective cooperative study; Results similar to those of the original study were achieved in Stages I and IIA (MDAH substaging) with a locoregional failure rate of 7%; In Stage IIB, the locoregional failure rate of 16% is also comparable in both studies; Locoregional failures in Stage III are slightly lower than those reported in Houston, probably reflecting differences in patient's prognostic factors in France and Texas; The 5-year survival rate obtained in advanced Stages (UICC FIGO staging) are among the highest in the literature (76% in Stage IIb, 62% in Stage IIIa and 50% in Stage IIIb); The rate of severe complications remains acceptable and decreased throughout the study thanks to a better use of computer dosimetry.

Entities:  

Mesh:

Year:  1988        PMID: 3280531     DOI: 10.1016/0360-3016(88)90080-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  [Rectal toxicity prediction based on accurate rectal surface dose summation for cervical cancer radiotherapy].

Authors:  Jia-Wei Chen; Hai-Bin Chen; Qiang He; Yu-Liang Liao; Xin Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-12-20

2.  [Prediction of rectal toxicity of radiotherapy for prostate cancer based on multi-modality feature and multi-classifiers].

Authors:  Qiang He; Xuetao Wang; Xin Li; Xin Zhen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-08-30

3.  Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Authors:  Mostafa Atri; Zheng Zhang; Farrokh Dehdashti; Susanna I Lee; Shamshad Ali; Helga Marques; Wui-Jin Koh; Kathleen Moore; Lisa Landrum; Jae Weon Kim; Paul DiSilvestro; Eric Eisenhauer; Frederick Schnell; Michael Gold
Journal:  Gynecol Oncol       Date:  2016-07-27       Impact factor: 5.482

Review 4.  Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma.

Authors:  Ludy Lutgens; Jacoba van der Zee; Madelon Pijls-Johannesma; Danielle Fm De Haas-Kock; Jeroen Buijsen; Ghislaine Apg van Mastrigt; Guido Lammering; Dirk K M De Ruysscher; Philippe Lambin
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

5.  Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233.

Authors:  Mostafa Atri; Zheng Zhang; Helga Marques; Jeremy Gorelick; Mukesh Harisinghani; Aslam Sohaib; Dow-Mu Koh; Steven Raman; Michael Gee; Haesun Choi; Lisa Landrum; Robert Mannel; Linus Chuang; Jian Qin Michael Yu; Carolyn Kay McCourt; Michael Gold
Journal:  Eur J Radiol Open       Date:  2015

6.  Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy.

Authors:  Primoz Petric; Robert Hudej; Noora Al-Hammadi; Barbara Segedin
Journal:  Radiol Oncol       Date:  2016-11-09       Impact factor: 2.991

7.  Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons - the APROVE-trial.

Authors:  N Arians; K Lindel; J Krisam; K Herfarth; D Krug; S Akbaba; J Oelmann-Avendano; J Debus
Journal:  Radiat Oncol       Date:  2017-11-28       Impact factor: 3.481

8.  Definitive radiotherapy for uterine cervix cancer: long term results for patients treated in the period from 1998 till 2002 at the Institute of Oncology Ljubljana.

Authors:  Helena Barbara Zobec Logar; Barbara Segedin; Robert Hudej; Primoz Petric
Journal:  Radiol Oncol       Date:  2013-07-30       Impact factor: 2.991

9.  Comparing treatment outcomes of stage IIIB cervical cancer patients between those with and without lower third of vaginal invasion.

Authors:  Kanyarat Katanyoo
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.